PSA Testing Patterns Vary By Medical Specialty

 Email not displaying correctly?
View it in your browser.
G2 LogoLab and Pathology Insider Logo
 
February 16, 2016
placeholder OVERPAYMENTS
Long-Awaited Final Rule Clarifies 60-day Repayment Deadline
By Kelly A. Briganti, Editorial Director, G2 Intelligence
Labs and other providers are required by a provision enacted in the Affordable Care Act to return to Medicare overpayments within 60 days of…
Read More
placeholder CLIA
Walgreens Tells Theranos to Fix Problems or Lose Pact
By Ron Shinkman, Editor, Laboratory Industry Report
Walgreens has told Theranos to get its act together, or get out…
Read More

placeholder PRECISION MEDICINE
PSA Testing Patterns Vary By Medical Specialty
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies
Prostate specific antigen (PSA) testing varies significantly by physician specialty, according to a research letter published online Feb. 8 in…
Read More
placeholder FUNDING
Shire and ACMG Partner to Support Medical Geneticist Training
By Kelly A. Briganti, Editorial Director, G2 Intelligence
"As a result of advances in the area of genetic and genomic research and diagnostic testing, it is anticipated that the need for…
Read More
placeholder EMERGING TESTS
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
By Stephanie Murg, Managing Director, G2 Intelligence
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
Read More

Follow on Twitter |  Forward to a Friend

For questions concerning delivery of this email, please contact customer service at: (888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2016, All rights reserved.
Plain Language Media LLLP
PO Box 509
New London, CT 06320